Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-01 7:09 pm Purchase |
2024-02-20 | 13G | Iovance Biotherapeutics, Inc. IOVA |
PERCEPTIVE ADVISORS LLC | 19,221,743 6.900% |
7,242,328 (+60.46%) |
Filing History |
| 2024-02-29 7:45 pm Purchase |
2024-02-29 | 13D | LianBio LIANY |
PERCEPTIVE ADVISORS LLC | 57,850,841 53.400% |
1,530,881 (+2.72%) |
Filing History |
| 2024-02-23 4:16 pm Unchanged |
2024-02-23 | 13G | enVVeno Medical Corporation NVNO |
PERCEPTIVE ADVISORS LLC | 1,394,716 9.900% |
0 (Unchanged) |
Filing History |
| 2024-02-14 5:14 pm Sale |
2023-12-31 | 13G | Rain Enhancement Technologies Holdco Inc RAIN |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-2,483,619 (Position Closed) |
Filing History |
| 2024-02-14 4:56 pm Purchase |
2023-12-31 | 13G | Forte Biosciences, Inc. FBRX |
PERCEPTIVE ADVISORS LLC | 145,345 9.900% |
234 (+0.16%) |
Filing History |
| 2024-02-14 4:52 pm Unchanged |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
PERCEPTIVE ADVISORS LLC | 4,580,249 5.900% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:52 pm Unchanged |
2023-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 8,593,586 14.600% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
PERCEPTIVE ADVISORS LLC | 4,776,306 9.900% |
1,462,523 (+44.13%) |
Filing History |
| 2024-02-14 4:50 pm Sale |
2023-12-31 | 13G | Bellerophon Therapeutics, Inc. BLPH |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-930,000 (Position Closed) |
Filing History |
| 2024-02-14 4:49 pm Sale |
2023-12-31 | 13G | ADMA Biologics, Inc. ADMA |
PERCEPTIVE ADVISORS LLC | 6,433,369 2.800% |
-5,466,886 (-45.94%) |
Filing History |
| 2024-02-14 4:49 pm Unchanged |
2023-12-31 | 13G | Orchestra BioMed Holdings, Inc. OBIO |
PERCEPTIVE ADVISORS LLC | 2,432,089 6.800% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:48 pm Purchase |
2023-12-31 | 13G | Arcellx, Inc. ACLX |
PERCEPTIVE ADVISORS LLC | 4,544,809 8.800% |
1,946,504 (+74.91%) |
Filing History |
| 2024-02-14 4:47 pm Purchase |
2023-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
PERCEPTIVE ADVISORS LLC | 7,099,182 16.900% |
2,060,199 (+40.89%) |
Filing History |
| 2024-02-14 4:46 pm Sale |
2023-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
PERCEPTIVE ADVISORS LLC | 4,024,400 3.500% |
-1,254,562 (-23.77%) |
Filing History |
| 2024-02-14 4:46 pm Sale |
2023-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-2,860,000 (Position Closed) |
Filing History |
| 2024-02-14 4:44 pm Sale |
2023-12-31 | 13G | Zymeworks Inc. ZYME |
PERCEPTIVE ADVISORS LLC | 1,074,807 1.500% |
-3,436,468 (-76.18%) |
Filing History |
| 2024-02-14 4:41 pm Purchase |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
PERCEPTIVE ADVISORS LLC | 2,139,950 6.200% |
340,995 (+18.96%) |
Filing History |
| 2024-02-14 4:41 pm Purchase |
2023-12-31 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX |
PERCEPTIVE ADVISORS LLC | 3,436,600 8.300% |
190,432 (+5.87%) |
Filing History |
| 2024-02-14 4:40 pm Purchase |
2023-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
PERCEPTIVE ADVISORS LLC | 1,068,497 4.000% |
1,068,497 (New Position) |
Filing History |
| 2024-02-14 4:39 pm Purchase |
2023-12-31 | 13D | MeiraGTx Holdings plc MGTX |
PERCEPTIVE ADVISORS LLC | 11,442,562 18.000% |
35,999 (+0.32%) |
Filing History |